组胺受体 (Histamine Receptor) 是一类 G 蛋白偶联受体,其内源性配体为组胺。已知有四种组胺受体:H1 受体、H2 受体、H3 受体、H4 受体。H1 受体是属于视紫红质样 G 蛋白偶联受体家族的组胺受体。该受体由生物胺组胺激活,在全身表达,具体而言,在平滑肌、血管内皮细胞、心脏和中枢神经系统中。H2 受体通过 Gs 与腺苷酸环化酶正向偶联。它是一种强效的 cAMP 生成刺激剂,可激活蛋白激酶 A。组胺 H3 受体在中枢神经系统中表达,在周围神经系统中表达较少,在周围神经系统中,它们在突触前组胺能神经元中充当自受体,并通过反馈抑制组胺合成和释放来控制组胺周转。组胺 H4 受体已被证明参与介导嗜酸性粒细胞形状变化和肥大细胞趋化性。
Histamine Receptors are a class of G protein-coupled receptors with histamine as their endogenous ligand. There are four known histamine receptors: H1 receptor, H2 receptor, H3 receptor, H4 receptor. The H1 receptor is a histamine receptor belonging to the family of Rhodopsin-like G-protein-coupled receptors. This receptor, which is activated by the biogenic amine histamine, is expressed throughout the body, to be specific, in smooth muscles, on vascular endothelial cells, in the heart, and in the central nervous system. H2 receptors are positively coupled to adenylate cyclase via Gs. It is a potent stimulant of cAMP production, which leads to activation of Protein Kinase A. Histamine H3 receptors are expressed in the central nervous system and to a lesser extent the peripheral nervous system, where they act asautoreceptors in presynaptic histaminergic neurons, and also control histamine turnover by feedback inhibition of histamine synthesis and release. The Histamine H4 receptor has been shown to be involved in mediating eosinophil shape change and mast cell chemotaxis.
6-O-Senesioyl plenolin 是一种发现于 Centipeda minima 的倍半萜内酯,具有抗过敏活性,可抑制肥大细胞释放组胺 (IC50 = 18 μM),并在被动皮肤过敏试验中抑制色素渗出,因此可用于过敏的相关研究。
AHR-1911(10-Undecen-1-yl-Thiopseudourea Iodide;Isothiuronium)是一种硫代硫脲类抗炎剂和抗肿瘤剂,对烧伤性皮肤具有改善作用,经皮内注射后可产生类似组胺的效果,并可能降低麻醉犬的动脉压,同时能够抑制肿瘤生长并降低微粒体和C-多核糖体的蛋白质合成。
MFDCH016 是一种强效的 HDAC1/6(IC50 = 38/59 nM)和 CDK4/6(IC50 = 680/720 nM)抑制剂,可诱导 MCF-7 细胞凋亡(apoptosis)并将细胞周期阻滞于 G2/M 期和 G0/G1 期,通过调节 HDAC-p21-CDK 信号通路增加乙酰化 H3 和 p21 的水平,可用于乳腺癌的研究。
Histamine-α,α,β,β-d4 (dihydrochloride) 是 Histamine 的氘代物,而 Histamine 是一种参与局部免疫反应的有机含氮化合物,可调节肠道生理功能,并作为神经递质发挥作用。
Histamine/OVA 是由 Histamine (MS-J66916) 与鸡卵白蛋白 (OVA) 缀合而成的抗原-佐剂偶联物,通过将抗原与蛋白佐剂缀合可增强疫苗模型中抗原特异性抗体的产生,且该缀合物不会影响蛋白质折叠或破坏主要表位,并可增强交叉呈递和抗原特异性 T 细胞的产生。
© 2026 MolStrong. 保留所有权利。粤ICP备2023004355号
可通过CAS号进行批量搜索,一行一个CAS号